CORT insider transactions
Corcept Therapeutics Incorporated (CORT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CORT
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $1,412,000 worth of shares (20,000 units at $70.60) as part of a pre-agreed trading plan (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas was granted 1,074 shares and covered exercise/tax liability with 269 shares, increasing direct ownership by 13% to 7,035 units (SEC Form 4) (tax liability)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William was granted 1,754 shares, increasing direct ownership by 79% to 3,985 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean exercised 25,000 shares at a strike of $8.27, sold $1,755,183 worth of shares (25,000 units at $70.21) as part of a pre-agreed trading plan, was granted 1,230 shares and covered exercise/tax liability with 452 shares, increasing direct ownership by 9% to 9,755 units (SEC Form 4) (for withholding tax)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak exercised 40,000 shares at a strike of $19.26, sold $2,800,004 worth of shares (40,000 units at $70.00) as part of a pre-agreed trading plan, was granted 1,268 shares and covered exercise/tax liability with 395 shares, increasing direct ownership by 6% to 16,130 units (SEC Form 4) (tax withholding)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles was granted 1,552 shares and covered exercise/tax liability with 358 shares, increasing direct ownership by 5% to 25,681 units (SEC Form 4) to satisfy tax liability4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K gifted 300,000 shares, received a gift of 300,000 shares and sold $895,252 worth of shares (12,837 units at $69.74) as part of a pre-agreed trading plan (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas sold $325,000 worth of shares (5,000 units at $65.00), decreasing direct ownership by 45% to 6,230 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean exercised 75,000 shares at a strike of $8.27 and sold $4,918,944 worth of shares (75,000 units at $65.59) as part of a pre-agreed trading plan (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N received a gift of 9,011 shares and gifted 901,067 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Baker G Leonard Jr4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Alton Gregg H4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Wilson James N4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Swisher Daniel N Jr4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Murray Joshua M.4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Mahoney David L4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Director Park Kimberly4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles received a gift of 2,000 shares and gifted 5,300 shares, decreasing direct ownership by 18% to 24,487 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William sold $1,036,600 worth of shares (20,000 units at $51.83) as part of a pre-agreed trading plan and exercised 20,000 shares at a strike of $21.65 (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $2,003,860 worth of shares (40,000 units at $50.10) as part of a pre-agreed trading plan (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N gifted 2,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Wilson James N4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Belanoff Joseph K4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Wilson James N4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Baker G Leonard Jr4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N gifted 28,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Mahoney David L exercised 30,000 shares at a strike of $5.86, covered exercise/tax liability with 5,469 shares, gifted 24,531 shares and acquired 24,531 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 8,233 shares at a strike of $21.65 and sold $296,346 worth of shares (8,233 units at $35.99) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas was granted 796 shares and covered exercise/tax liability with 89 shares, increasing direct ownership by 7% to 11,230 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean was granted 908 shares and covered exercise/tax liability with 110 shares, increasing direct ownership by 10% to 8,977 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles was granted 998 shares and covered exercise/tax liability with 121 shares, increasing direct ownership by 1% to 79,503 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William was granted 996 shares, increasing direct ownership by 81% to 2,231 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak was granted 794 shares and covered exercise/tax liability with 96 shares, increasing direct ownership by 5% to 15,257 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Officer Lyon Joseph Douglas4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Belanoff Joseph K4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Mokari Atabak4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Officer Maduck Sean4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Business Officer Robb Gary Charles4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Hunt Hazel4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Development Officer Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N exercised 100,000 shares at a strike of $3.88, covered exercise/tax liability with 10,636 shares, gifted 89,364 shares and acquired 89,364 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean gifted 54,570 shares and acquired 54,570 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Scientific Officer Hunt Hazel exercised 150,000 shares at a strike of $3.88 and covered exercise/tax liability with 77,968 shares, increasing direct ownership by 39% to 255,437 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $817,334 worth of shares (20,000 units at $40.87) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Baker G Leonard Jr exercised 140,000 shares at a strike of $11.49 (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $703,656 worth of shares (20,000 units at $35.18) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Baker G Leonard Jr gifted 0 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles exercised 145,000 shares at a strike of $3.88 and covered exercise/tax liability with 80,284 shares, increasing direct ownership by 465% to 78,626 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K exercised 550,000 shares at a strike of $3.88, covered exercise/tax liability with 306,846 shares, gifted 243,154 shares and acquired 243,154 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N acquired 400,000 shares and gifted 400,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65, sold $1,601,526 worth of shares (20,000 units at $80.08), was granted 448 shares, gifted 787 shares and acquired 787 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean sold $1,590,490 worth of shares (20,000 units at $79.52), was granted 410 shares, covered exercise/tax liability with 135 shares and exercised 20,000 shares at a strike of $8.27, increasing direct ownership by 3% to 8,179 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas sold $397,632 worth of shares (5,000 units at $79.53), was granted 356 shares, covered exercise/tax liability with 110 shares and exercised 5,000 shares at a strike of $13.56, increasing direct ownership by 2% to 10,523 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak was granted 356 shares and covered exercise/tax liability with 118 shares, increasing direct ownership by 2% to 14,559 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles covered exercise/tax liability with 148 shares and was granted 448 shares, increasing direct ownership by 2% to 13,910 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $3,190,796 worth of shares (40,000 units at $79.77) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Amendment: Chief Development Officer Guyer William gifted 5,287 shares, acquired 5,287 shares and sold $364,070 worth of shares (4,500 units at $80.90), closing all direct ownership in the company (SEC Form 4)4/A - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William sold $364,070 worth of shares (4,500 units at $80.90), decreasing direct ownership by 85% to 787 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)